Reuters logo
BRIEF-Cellular Biomedicine Group reports qtrly ‍loss per share $0.43
November 9, 2017 / 2:06 PM / a month ago

BRIEF-Cellular Biomedicine Group reports qtrly ‍loss per share $0.43

Nov 9 (Reuters) - Cellular Biomedicine Group Inc

* Cellular Biomedicine Group reports third quarter financial results and recent operational highlights

* Cellular Biomedicine Group Inc- ‍$16.3 million cash and cash equivalents as of September 30, 2017 as compared to $27.3 million as of June 30, 2017​

* Cellular Biomedicine Group Inc - Qtrly ‍loss per share $0.43​

* Cellular Biomedicine Group Inc - Qtrly net sales and revenue $106,787 versus $10,012‍​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below